PD
BIIB icon

Point72 (DIFC)’s Biogen BIIB Stock Holding History

Point72 (DIFC)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$25.1K – 1215
2025
Q2 		$25.1K Sell
200
-16,600
-99% -$2.07M ﹤0.01% 1201
2025
Q1 		$2.3M Buy
16,800
+15,500
+1,192% +$2.22M 0.09% 283
2024
Q4 		$199K Sell
1,300
-9,300
-88% -$1.57M 0.01% 872
2024
Q3 		$2.05M Sell
10,600
-29,000
-73% -$6.07M 0.07% 325
2024
Q2 		$9.18M Buy
39,600
+37,900
+2,229% +$8.24M 0.33% 65
2024
Q1 		$367K Buy
+1,700
New +$398K 0.01% 822

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Point72 (DIFC)'s BIIB Position: Q3 2025 in Review

Point72 (DIFC) reduced its Biogen (BIIB) stake by 95% in Q3 2025, selling an estimated $2.1M and leaving 772 shares worth $108K. The position accounts for 0.01% of the portfolio, ranked #563.

Point72 (DIFC) first reported a position in BIIB in Q1 2024 and has held it in 5 quarters since. The position peaked at $6.82M in Q1 2025. 908 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Point72 (DIFC) held 772 shares of Biogen worth $108K as of Q3 2025.
  • Point72 (DIFC) sold 15,529 Biogen shares in Q3 2025, an estimated $2.1M.
  • Biogen made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #563 holding.
  • Point72 (DIFC) first reported a position in Biogen in Q1 2024 and has held it in 5 quarters since.
  • Point72 (DIFC)'s Biogen position peaked at $6.82M in Q1 2025.
  • 908 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.